Unicuspid Aortic Valve in Patients Undergoing the Ross
Procedure

J 2023

Unicuspid Aortic Valve in Patients Undergoing the Ross Procedure

GOFUS, Jan, Petr FILA, Martin VOBORNIK, Jiri ONDRASEK, Petr NĚMEC et. al.

Basic information

Original name

Unicuspid Aortic Valve in Patients Undergoing the Ross Procedure

Authors

GOFUS, Jan (203 Czech Republic), Petr FILA (203 Czech Republic, guarantor, belonging to the institution), Martin VOBORNIK (203 Czech Republic), Jiri ONDRASEK (203 Czech Republic), Petr NĚMEC (203 Czech Republic, belonging to the institution), Jan ŠTĚRBA (203 Czech Republic, belonging to the institution), Eva CERMAKOVA (203 Czech Republic), Martin TUNA (203 Czech Republic) and Jan VOJACEK (203 Czech Republic)

Edition

Annals of Thoracic Surgery, New York, Elsevier Science Inc. 2023, 0003-4975

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30201 Cardiac and Cardiovascular systems

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 4.600 in 2022

RIV identification code

RIV/00216224:14110/23:00130667

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1016/j.athoracsur.2022.03.061

UT WoS

000944472800001

Keywords in English

Unicuspid Aortic Valve; Ross Procedure

Abstract

V originále

BACKGROUND The prevalence and outcomes of the unicuspid aortic valve (UAV) in patients undergoing the Ross procedure have been strongly underreported in the current literature. We sought to evaluate this in comparison with bicuspid (BAV) and tricuspid valve (TAV) in our Ross cohort.METHODS This was a retrospective observational study of patients undergoing the Ross procedure at 2 dedicated centers between 2009 and 2020. Primary end points were the risks of midterm autograft reoperation and the onset of at least moderate aortic regurgitation during follow-up. The secondary end point was to compare the perioperative out-comes between the groups.RESULTS Included in the analysis were 286 patients, of those 39% with UAV, 52% with BAV, and 9% with TAV. UAV patients were operated on at the youngest age (P < .001) and more often for a combined hemodynamic aortic valve pathology (P = .02). They had the largest aortic root dimensions: annulus (P = .01), Valsalva sinuses (P = .11), sino-tubular junction (P = .001), and ascending aorta (P < .0001). The risks of reoperation (P = .86) and the onset of aortic regurgitation (P = .75) were comparable among the groups over the follow-up of 4.1 years. There was no difference in perioperative outcomes.CONCLUSIONS UAV is a separate unit characterized by a distinct hemodynamic pathology and generated aortopathy. It is not associated with a higher risk of reoperation or new onset of aortic regurgitation after the Ross procedure in the midterm postoperatively. At the current state, UAV remains acceptable for the Ross procedure.

Citovat

GOFUS, Jan, Petr FILA, Martin VOBORNIK, Jiri ONDRASEK, Petr NĚMEC, Jan ŠTĚRBA, Eva CERMAKOVA, Martin TUNA and Jan VOJACEK. Unicuspid Aortic Valve in Patients Undergoing the Ross Procedure. Annals of Thoracic Surgery. New York: Elsevier Science Inc., 2023, vol. 115, No 3, p. 626-631. ISSN 0003-4975. Available from: https://dx.doi.org/10.1016/j.athoracsur.2022.03.061.

@article{2278239,
   author = {Gofus, Jan and Fila, Petr and Vobornik, Martin and Ondrasek, Jiri and Němec, Petr and Štěrba, Jan and Cermakova, Eva and Tuna, Martin and Vojacek, Jan},
   article_location = {New York},
   article_number = {3},
   doi = {http://dx.doi.org/10.1016/j.athoracsur.2022.03.061},
   keywords = {Unicuspid Aortic Valve; Ross Procedure},
   language = {eng},
   issn = {0003-4975},
   journal = {Annals of Thoracic Surgery},
   title = {Unicuspid Aortic Valve in Patients Undergoing the Ross Procedure},
   url = {https://www.sciencedirect.com/science/article/abs/pii/S0003497522005124?via%3Dihub},
   volume = {115},
   year = {2023}
}

TY  - JOUR
ID  - 2278239
AU  - Gofus, Jan - Fila, Petr - Vobornik, Martin - Ondrasek, Jiri - Němec, Petr - Štěrba, Jan - Cermakova, Eva - Tuna, Martin - Vojacek, Jan
PY  - 2023
TI  - Unicuspid Aortic Valve in Patients Undergoing the Ross Procedure
JF  - Annals of Thoracic Surgery
VL  - 115
IS  - 3
SP  - 626-631
EP  - 626-631
PB  - Elsevier Science Inc.
SN  - 00034975
KW  - Unicuspid Aortic Valve
KW  - Ross Procedure
UR  - https://www.sciencedirect.com/science/article/abs/pii/S0003497522005124?via%3Dihub
N2  - BACKGROUND The prevalence and outcomes of the unicuspid aortic valve (UAV) in patients undergoing the Ross procedure have been strongly underreported in the current literature. We sought to evaluate this in comparison with bicuspid (BAV) and tricuspid valve (TAV) in our Ross cohort.METHODS This was a retrospective observational study of patients undergoing the Ross procedure at 2 dedicated centers between 2009 and 2020. Primary end points were the risks of midterm autograft reoperation and the onset of at least moderate aortic regurgitation during follow-up. The secondary end point was to compare the perioperative out-comes between the groups.RESULTS Included in the analysis were 286 patients, of those 39% with UAV, 52% with BAV, and 9% with TAV. UAV patients were operated on at the youngest age (P < .001) and more often for a combined hemodynamic aortic valve pathology (P = .02). They had the largest aortic root dimensions: annulus (P = .01), Valsalva sinuses (P = .11), sino-tubular junction (P = .001), and ascending aorta (P < .0001). The risks of reoperation (P = .86) and the onset of aortic regurgitation (P = .75) were comparable among the groups over the follow-up of 4.1 years. There was no difference in perioperative outcomes.CONCLUSIONS UAV is a separate unit characterized by a distinct hemodynamic pathology and generated aortopathy. It is not associated with a higher risk of reoperation or new onset of aortic regurgitation after the Ross procedure in the midterm postoperatively. At the current state, UAV remains acceptable for the Ross procedure.
ER  -

GOFUS, Jan, Petr FILA, Martin VOBORNIK, Jiri ONDRASEK, Petr NĚMEC, Jan ŠTĚRBA, Eva CERMAKOVA, Martin TUNA and Jan VOJACEK. Unicuspid Aortic Valve in Patients Undergoing the Ross Procedure. \textit{Annals of Thoracic Surgery}. New York: Elsevier Science Inc., 2023, vol.~115, No~3, p.~626-631. ISSN~0003-4975. Available from: https://dx.doi.org/10.1016/j.athoracsur.2022.03.061.

Detailed Information on Publication Record